AI adoption in pharma drops sharply in the domains that matter most for discovery.
Tim Wahlberg
Advertisement
Author’s note: Tim Wahlberg is Interim President at CAS, where he led the recent launch of CAS NewtonSM, the science-smart agentic AI built for scientific discovery.
Articles by Tim Wahlberg
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on PharmExec
1
2026 Pharm Exec Top 50 Companies
2
Pharma’s New Growth Equation: Smarter Deals, Stronger Science, Rising Costs
3
M&A Roundup: LEO Pharma Acquires Dersimelagon, BioMarin Acquires Alesta, OmniAb Enters collaboration with Eli Lilly, Chugai and GSK Enter License Agreement for AID351
4
Henlius Enters $322 Million Strategic Collaboration with Sandoz
5